Effectiveness of urokinase for salvaging occluded central venous access devices
Intended for healthcare professionals
Evidence & Practice Previous     Next

Effectiveness of urokinase for salvaging occluded central venous access devices

Kelsey Dyson-Fleming Nursing student, Royal Manchester Children’s Hospital

Fibrinolytic drugs, such as urokinase, are used as a first line of action to clear the blockage, yet the effectiveness of fibrinolytic drugs is uncertain. Salvaging occluded central venous access devices (CVADs) prevents the patient needing a replacement, which would be inserted as a surgical procedure. Side effects and costs associated with inserting a new CVAD are higher than those for instilling urokinase.

Nursing Children and Young People. 30, 2, 20-20. doi: 10.7748/ncyp.30.2.20.s20

Your organisation does not have access to this article
Recommend to your librarian
RCNi-Plus
Already have access? Log in

OR

3-month trial offer for �5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more